Alan H. Auerbach, President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 21,920 shares at $3.70 ($81K) on 2024-07-17, disclosed to the SEC on 2024-07-18.
Scheduled sale ($81k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2025-07-10 | $333K | — | Filing → |
| PBYI | SELL | 2025-01-03 | $213K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $124K | — | Filing → |